Back to top

Zacks Value Trader Highlights: General Electric, Macy's, Biogen, Chipotle and Exxon Mobil

Read MoreHide Full Article

For Immediate Release

Chicago, IL – November 27, 2017 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (

Should You Buy Beaten Down Bluechip Stocks?

Welcome to Episode #69 of the Value Investor Podcast.

Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio service, shares some of her top value investing tips and stock picks.

Not everything is gumdrops and roses for every stock right now, despite the indexes hitting new all-time highs.

Some large cap names have sold off in 2017, including a couple that have hit multi-year lows.

Tracey hears a lot of people calling those stocks “value” stocks, but are they? Does a sell-off in the shares automatically make it a value?

Value Stocks Are More Than the Chart

Tracey has done podcasts on value stocks that were breaking out, so the chart isn’t the end all, be all, of value investing.

Value investors buy stocks trading at a discount to their earnings. Therefore, earnings are the key. Are they rising or falling? Investors need to know avoid the “value trap” scenario where a stock appears cheap, but that’s because the earnings are on the decline.

Tracey took a look at five blue chip stocks that have been in the news recently, mostly for their weak stocks.

Are These 5 Blue Chip Stocks Value Stocks?

1.      General Electric (GE - Free Report)  has plunged to 5-year lows. Surely, with all the bad news that’s there, including a dividend cut, there must be some value, right? However, it’s forward P/E is 17.2, which still isn’t that cheap. What does the earnings forecast reveal?

2.     Macy’s (M - Free Report)  is dirt cheap. It trades with a forward P/E of just 5.9. Shares are down 43% this year, however, on worries that the department stores are doomed. But are the earnings estimates really signaling the end is near?

3.     Biogen (BIIB - Free Report)  was weak through May and has since rallied. Shares, however, are still well under the 2015 highs. It trades with an attractive forward P/E of 14.3 but does it have the earnings growth to get the thumbs up?

4.     Chipotle (CMG - Free Report)  is still down over 20% year-to-date and near 5-year lows. But are the shares cheap enough, and the earnings growing fast enough, to qualify it for the coveted value stock designation?

5.     Exxon Mobil (XOM - Free Report)  shares are weak compared to the S&P 500. Exxon is down 11% year-to-date, but are off their 2017 lows. With crude hanging out above $50 pretty consistently, are the oil stock earnings finally showing a rebound?

Remember, the Price-to-Earnings ratio is predicated on both price AND earnings. Value investors need to check those earnings before deciding that a stock is “cheap.”

What else should you know about beaten down blue-chip stocks?

Listen to this week’s podcast to find out.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>

Tracey Ryniec is the Value Stock Strategist for She is also the Editor of the Insider Trader and Value Investor services. You can follow her on twitter at @TraceyRyniec and she also hosts the Zacks Market Edge Podcast on iTunes.

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!  Click here for your free subscription to Profit from the Pros.

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release.